Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lombard Medical Inc EVARF

Lombard Medical, Inc. is a medical device company. The Company is focused solely on the minimally invasive treatment of aortic disease. The Company partners with MicroPort Endovastec to offer Minos abdominal aortic aneurysm (AAA) stent-graft, the Hercules TAA stent graft and the Castor Branched Thoracic stent graft, in addition to its own Aorfix and Altura stent grafts. The Company’s products... see more

Recent & Breaking News (GREY:EVARF)

OTC Markets Group Welcomes Lombard Medical to OTCQX

PR Newswire November 9, 2017

Mid-Afternoon Market Update: MarineMax Gains On Earnings Beat; Nautilus Shares Plunge

Benzinga.com  October 31, 2017

Mid-Day Market Update: Trex Rises After Strong Q3 Results; Under Armour Shares Slide

Benzinga.com  October 31, 2017

Lombard Medical Reports First Half and Third Quarter 2017 Financial Results

Business Wire October 31, 2017

13 Stocks Moving In Monday's After-Hours Session

Benzinga.com  October 30, 2017

Lombard Medical Announces Shares to Trade on OTCQX

Business Wire October 30, 2017

Lombard Medical’s New Delivery System for Aorfix™ Endovascular Aortic Aneurysm Repair System Launched in Japan

Business Wire September 26, 2017

Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing

Business Wire September 20, 2017

Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability

Business Wire September 13, 2017

Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System

Business Wire May 15, 2017

Lombard Medical’s Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium

Business Wire May 4, 2017

Lombard Medical Appoints New CEO

Business Wire April 20, 2017

Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

Business Wire April 3, 2017

Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft

Business Wire February 7, 2017

Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

Business Wire January 5, 2017

Lombard Medical and MicroPort Scientific Corporation Announce Strategic Partnership and Investment Agreement

Business Wire December 19, 2016

Positive Long-Term Data for Lombard Medical’s Aorfix™ Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies

GlobeNewswire December 5, 2016

Multi-Centre Early Experience and Data Presented on Lombard Medical’s Altura® Endovascular Stent Graft at the 43rd Annual VEITHsymposium™

GlobeNewswire November 21, 2016

Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency

GlobeNewswire November 15, 2016

Lombard Medical Announces Scientific Presentations on Aorfix™ and Altura® Endovascular Stent Grafts at the 43nd Annual VEITHsymposium™

GlobeNewswire November 14, 2016